ARCHIVES

Finasteride Cut Risk Of Prostate Cancer In Large Trial, But Value In Clinic Unclear.

This article is from The Cancer Letter archive.

Vol. 29 No. 26 | June 27, 2003

Download PDF Visit The Full Archive

Related Articles

White House Plans to Name Broder NCI Director, Overruling Wyngaarden, Who Support Rabson

December 2, 1988

In Brief: Calabresi Named To President’s Cancer Panel; Mays Leaves NCI Technology Office For IVAX

May 5, 1995

Cancer Meetings Listed

November 1, 1996

Two Avastin Trials Show OS Benefit In Advanced Disease

August 27, 2010

Misconduct Finding Is ‘Rare,’ OSI official Tells NCAB

June 14, 1991

Critics of FDA misunderstand Bayesian analysis, statisticians say.

August 5, 2005